FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy, cardiology, and can be used for diagnosing pulmonary oedema in patients with dyspnoea. Transthoracic ultrasonic examination of lungs and pleura is performed on both sides in each intercostal space with a linear ultrasonic transducer at frequency of 7-12 MHz before and after six-minute walking. Interstitial cardiogenic pulmonary oedema is diagnosed when determining from two sides in each intercostal space at least four B-lines before six-minute walking, if observing an increase in the number of B-lines in each intercostal space by three or more after a six-minute walk, and if observing a smooth pleural line with its thickness of not more than 1 mm on both sides. Interstitial non-cardiogenic pulmonary oedema is diagnosed by determining at least one side of more than one intercostal space of at least four B-lines before a six-minute walk, if there is no increase in all intercostal spaces of the number of B-lines after a six-minute walk and if there is at least one side of an irregular pleural line with its thickness of more than 1 mm. Cardiogenic and non-cardiogenic interstitial pulmonary oedema is excluded when determining from both sides in all intercostal spaces not more than three B-lines before six-minute walk, in the absence of an increase in the number of B-lines in all intercostal spaces after a six-minute walk and with a smooth pleural line with its thickness of not more than 1 mm on both sides.
EFFECT: method provides simple and non-invasive differential diagnosis of interstitial cardiogenic and non-cardiogenic pulmonary oedema or exclusion of cardiogenic and non-cardiogenic interstitial pulmonary oedema by counting B-lines after physical activity.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE SEVERITY OF PNEUMONIA WITH COVID-19 USING AN ULTRASONIC EXAMINATION METHOD | 2020 |
|
RU2729368C1 |
METHOD FOR DETERMINING DIASTOLIC DYSFUNCTION OF THE RIGHT VENTRICLE | 2018 |
|
RU2696076C1 |
METHOD OF PREDICTING THE COURSE OF PNEUMONIA IN COVID-19 BASED ON THE COLLATION THE RESULTS OF DMS AND MSCT OF LUNGS | 2020 |
|
RU2736341C1 |
METHOD FOR DIAGNOSING CHRONIC HEART FAILURE IN PATIENTS WITH ARTERIAL HYPERTENSION AND SENILE ASTHENIA SYNDROME AT AGE OF 80 YEARS AND OLDER | 2024 |
|
RU2832935C1 |
METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
METHOD FOR STIMULATING ACUTE PULMONARY INJURY | 2010 |
|
RU2456677C2 |
METHOD FOR EARLY DIAGNOSIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES BY ANALYSIS OF HEART RATE VARIABILITY | 2023 |
|
RU2800862C1 |
METHOD FOR PREDICTING CHRONIC HEART FAILURE | 2002 |
|
RU2234240C2 |
METHOD OF EXAMINATION AND ASSESSMENT OF CLINICAL EFFECTIVENESS IN PATIENTS WITH PULMONARY DISEASES | 2020 |
|
RU2739413C1 |
METHOD FOR ESTIMATING PULMONARY TISSUE STATE | 1989 |
|
RU2065288C1 |
Authors
Dates
2025-01-28—Published
2024-04-26—Filed